Results 241 to 250 of about 44,866 (298)

The Molecular Basis of Partial Reversal or Significant Slowing of ALS, Parkinson's Disease, and Lewy Body Dementia by Mesenchymal Exosomes/Secretome. [PDF]

Int J Mol Sci
Prodromos CC, Del Villar R, Striegel A, Pena G, Dixit R.   +4 more
europepmc   +1 more source

Administration of Schwann Cell‐Like Cells Differentiated From Tonsil‐Derived Mesenchymal Stem Cells Promotes Peripheral Nerve Regeneration by Inducing Macrophage Polarization in a Chronic Constriction Injury Model

Muscle &Nerve, Volume 74, Issue 3, Page 728-739, September 2026.
TMSC‐SCs were mixed with fibrin adhesive and administered into the sciatic nerve of CCI rats, and nerve conduction studies and histopathological observations confirmed the regeneration of the peripheral nerve and gastrocnemius muscle. In addition, the expression of M1 and M2 macrophage markers was observed after the administration of TMSC‐SCs. ABSTRACT
Yu Hwa Nam, Ji‐Sup Kim, Yoonji Yum, Juhee Yoon, Youbeen Cho, Jaeseung Lim, Saeyoung Park, Sung‐Chul Jung   +7 more
wiley   +1 more source

Human Secretomes, Plant Exosomes, and Hybrid Secretomes Intradermal Injections for Hair Regeneration: Experimental Study. [PDF]

Plast Reconstr Surg Glob Open
Adel N, Kolenda J, Thulesen J, Crespo FHG, Shen Y, Jo YK, Resendiz GYZ, Thulesen IV, Saucillo JR.   +8 more
europepmc   +1 more source

A Review of the Therapeutic Potential of Stem Cell‐Derived Nanocarriers to Treat Neurological Disorders

ChemistryOpen, Volume 15, Issue 9, September 2026.
Neurological disorders (NDs) are characterized by substantial loss of specific neurons, with Alzheimer's and Parkinson's diseases being the most frequent NDs and nearly 99% of all “foreign substances” are prohibited from entering the brain by the blood‐brain barrier (BBB) and the blood‐cerebrospinal fluid barrier (CFB).
Nnamdi Ikemefuna Okafor, Ahmed Abdelgader, Magdi Abobaker, Yahya E. Choonara   +3 more
wiley   +1 more source

Biotechnological Advancements in Ovine Bioactives: Mapping Protein Expression Trends and Immuno-Lipidomic Dynamics for Functional Food Applications. [PDF]

Int J Mol Sci
Triantaphyllopoulos KA, Bastas K, Moustridis N, Masoura M, Massouras T.   +4 more
europepmc   +1 more source

Histiocytosis development and clinical variation through the lens of genomics

The Journal of Pathology, Volume 270, Issue 1, Page 23-39, September 2026.
Abstract Histiocytic neoplasms are rare haematologic diseases characterised by clonal expansions of cells with a monocyte, macrophage or dendritic cell phenotype. Their clinical manifestations are diverse, ranging from indolent lesions to aggressive systemic disease.
Paul G Kemps, Astrid GS van Halteren, Tom van Wezel, Pancras CW Hogendoorn   +3 more
wiley   +1 more source

Intracavernosal UC-MSC secretome therapy for severe erectile dysfunction: a clinical anatomy pilot study with elastography and Doppler assessment. [PDF]

Front Reprod Health
Margiana R, Supardi S, Pramesti MPBD, Suroto H, I'tishom R, Amalia FL, Nugroho MI, Pratama AAT, Surya Atmaja MH, Jonathan Wibowo K, Fadhillah MR, Graciana T, Ramelan W, Jusuf AA.   +13 more
europepmc   +1 more source

The metabolic trap: <i>Candida parapsilosis</i> inhibits <i>Staphylococcus aureus</i> biofilm maturation by disrupting pH homeostasis and inducing premature exodus. [PDF]

J Med Microbiol
Furlong C, Mohapatra S, Harold D, Finlay E, Holland L.   +4 more
europepmc   +1 more source

Restoring neuroplasticity after CNS trauma: cell therapy approaches in spinal cord and traumatic brain injury. [PDF]

J Transl Med
Palha AT, Lima MF, Carvalho M, Campos J, Sampaio-Marques B, Salgado AJ.   +5 more
europepmc   +1 more source